A detailed history of Calamos Advisors LLC transactions in Stryker Corp stock. As of the latest transaction made, Calamos Advisors LLC holds 85,522 shares of SYK stock, worth $33.4 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
85,522
Previous 90,573 5.58%
Holding current value
$33.4 Million
Previous $32.7 Million 5.88%
% of portfolio
0.18%
Previous 0.2%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 24, 2025

SELL
$345.14 - $392.15 $1.74 Million - $1.98 Million
-5,051 Reduced 5.58%
85,522 $30.8 Million
Q3 2024

Nov 07, 2024

BUY
$315.94 - $371.96 $1.71 Million - $2.02 Million
5,428 Added 6.38%
90,573 $32.7 Million
Q2 2024

Jul 25, 2024

SELL
$324.3 - $354.67 $476,396 - $521,010
-1,469 Reduced 1.7%
85,145 $29 Million
Q1 2024

May 08, 2024

SELL
$293.94 - $358.71 $1.54 Million - $1.88 Million
-5,238 Reduced 5.7%
86,614 $31 Million
Q4 2023

Jan 31, 2024

BUY
$253.85 - $299.46 $5.93 Million - $7 Million
23,371 Added 34.13%
91,852 $27.5 Million
Q3 2023

Oct 25, 2023

BUY
$266.54 - $302.43 $50,109 - $56,856
188 Added 0.28%
68,481 $18.7 Million
Q2 2023

Jul 28, 2023

BUY
$271.49 - $305.09 $17,918 - $20,135
66 Added 0.1%
68,293 $20.8 Million
Q1 2023

May 03, 2023

SELL
$246.13 - $285.47 $1.46 Million - $1.69 Million
-5,914 Reduced 7.98%
68,227 $19.5 Million
Q4 2022

Jan 25, 2023

SELL
$205.51 - $253.93 $1.93 Million - $2.39 Million
-9,407 Reduced 11.26%
74,141 $0
Q3 2022

Oct 24, 2022

BUY
$189.27 - $231.83 $7,949 - $9,736
42 Added 0.05%
83,548 $16.9 Million
Q2 2022

Aug 01, 2022

BUY
$194.09 - $276.37 $333,834 - $475,356
1,720 Added 2.1%
83,506 $16.6 Million
Q1 2022

May 03, 2022

BUY
$245.33 - $277.77 $2.01 Million - $2.28 Million
8,195 Added 11.14%
81,786 $21.9 Million
Q4 2021

Feb 01, 2022

BUY
$236.63 - $276.44 $488,167 - $570,295
2,063 Added 2.88%
73,591 $19.7 Million
Q3 2021

Oct 26, 2021

BUY
$248.9 - $280.09 $1.13 Million - $1.27 Million
4,521 Added 6.75%
71,528 $18.9 Million
Q2 2021

Jul 22, 2021

BUY
$242.95 - $267.0 $2.58 Million - $2.84 Million
10,625 Added 18.84%
67,007 $17.4 Million
Q1 2021

Apr 12, 2021

BUY
$221.01 - $248.82 $246,426 - $277,434
1,115 Added 2.02%
56,382 $13.7 Million
Q4 2020

Jan 27, 2021

SELL
$202.01 - $245.04 $305,843 - $370,990
-1,514 Reduced 2.67%
55,267 $13.5 Million
Q3 2020

Oct 26, 2020

SELL
$177.77 - $215.81 $569,219 - $691,023
-3,202 Reduced 5.34%
56,781 $11.8 Million
Q2 2020

Jul 27, 2020

SELL
$144.67 - $207.03 $377,444 - $540,141
-2,609 Reduced 4.17%
59,983 $10.8 Million
Q1 2020

Apr 28, 2020

SELL
$126.5 - $225.1 $2.85 Million - $5.07 Million
-22,520 Reduced 26.46%
62,592 $10.4 Million
Q4 2019

Jan 15, 2020

SELL
$197.98 - $220.53 $148,682 - $165,618
-751 Reduced 0.87%
85,112 $17.9 Million
Q3 2019

Oct 21, 2019

BUY
$205.4 - $221.82 $830,843 - $897,261
4,045 Added 4.94%
85,863 $18.6 Million
Q2 2019

Aug 07, 2019

SELL
$180.24 - $205.58 $2.77 Million - $3.16 Million
-15,362 Reduced 15.81%
81,818 $16.8 Million
Q1 2019

Apr 12, 2019

BUY
$152.46 - $198.0 $204,143 - $265,122
1,339 Added 1.4%
97,180 $19.2 Million
Q4 2018

Jan 24, 2019

SELL
$145.0 - $178.65 $3.13 Million - $3.85 Million
-21,572 Reduced 18.37%
95,841 $15 Million
Q3 2018

Oct 22, 2018

SELL
$163.25 - $177.68 $1.21 Million - $1.31 Million
-7,400 Reduced 5.93%
117,413 $20.9 Million
Q2 2018

Jul 17, 2018

SELL
$155.17 - $179.78 $5.8 Million - $6.71 Million
-37,349 Reduced 23.03%
124,813 $21.1 Million
Q1 2018

Apr 13, 2018

SELL
$148.01 - $168.91 $9.32 Million - $10.6 Million
-62,935 Reduced 27.96%
162,162 $26.1 Million
Q4 2017

Feb 13, 2018

SELL
$143.51 - $159.74 $169,341 - $188,493
-1,180 Reduced 0.52%
225,097 $34.9 Million
Q3 2017

Oct 25, 2017

SELL
$138.36 - $147.87 $762,640 - $815,059
-5,512 Reduced 2.38%
226,277 $32.1 Million
Q2 2017

Aug 09, 2017

BUY
N/A
231,789
231,789 $32.2 Million

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $148B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.